Risperdal is an anti-psychotic drug which was approved by the FDA in 1993 initially to treat schizophrenia. Later, manufacturer Johnson & Johnson obtained the authorization to market Risperdal as a bipolar disorder treatment.
Before 2006, however, the drug was not approved to use for any treatment on children for any purpose. In that year, the FDA authorized Risperdal as a medication for pediatric bipolar disorder and symptoms such as irascibility or aggressiveness which are often displayed by some children with autism.
Risperdal gynecomastia litigation
A considerable number of Risperdal lawsuits have been filed charging that boys and young men who took the mediation suffered from the abnormal breast growth condition known as gynecomastia. Many of these cases are being handled as part of a consolidated proceeding in the Philadelphia Court of Common Pleas as risperdal class action lawsuit.
More than 420 lawsuits have been filed against Johnson & Johnson and their subsidiary Janssen Pharmaceutical, the maker of Risperdal for being the reason to cause serious personal injuries. Since 2012, Johnson & Johnson has settled certain claims involving Risperdal and gynecomastia.
In November 2013, Johnson & Johnson agreed to a $2.2 billion settlement over the fraudulent claims the manufacturer involved in the marketing of Risperdal. Those affected by the drug continue to file lawsuits because of the injuries it caused them.
Symptoms of gynecomastia may include:
- Tenderness in the breast
- Discharge from the nipples
- Swelling
These problems, as understood, are not be a critical health risk, however, they could generate emotional trauma for young men. It can also be challenging to reverse the impacts of gynecomastia and could require liposuction, mastectomy or surgery in extreme cases.
Dial 855-576-4392 to know more about the lawsuit and how you can claim for the damage awards.
Injured by the dangerous drug risperdal? 